← Leaderboards
Ingrid Oakley-Girvan
Medable, Inc.
$1,499,800
Attributed
$1,499,800
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,499,800 · 1
By mechanism
N43$1,499,800 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Anticancer Research”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$238,320,768
- Leonard Freedman · Leidos Biomedical Research, Inc.$161,112,755
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$39,889,328
- Dwayne Forquer · Leidos Biomedical Research, Inc.$29,410,041
- Leonard Freedmand · Leidos Biomedical Research, Inc.$22,652,885
Research focus
Anticancer ResearchBaseBehavioral AdherenceBiological MarkersClinical CareClinical ResearchClinical TrialsCloud BasedCohort StudiesComputer SoftwareContractsData AggregationDevicesDigitalDocumentationFlexibilityGraphical User InterfaceHealth BehaviorHealth StatusInformatics ToolInsightKnowledge BaseMachine Learning AlgorithmPhysiology